Your browser doesn't support javascript.
loading
Outcomes following minimally invasive approaches vs. open extended lobectomy for non-small cell lung cancer: a propensity-matched analysis of the National Cancer Database.
Chen, Tangbing; Chan, Ernest G; Huang, Binhao; Bertolaccini, Luca; Fernando, Hiran C; Tasoudis, Panagiotis T; Motas, Natalia; Pennathur, Arjun; Fang, Wentao; Zhang, Jie.
Affiliation
  • Chen T; Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chan EG; Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
  • Huang B; Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
  • Bertolaccini L; Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Fernando HC; Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Tasoudis PT; Department of Cardiothoracic Surgery, Allegheny General Hospital, Pittsburgh, PA, USA.
  • Motas N; Division of Cardiothoracic Surgery, Department of Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Pennathur A; Department of Thoracic Surgery, Institute of Oncology Bucharest, Bucharest, Romania.
  • Fang W; Clinic of Thoracic Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Zhang J; Department of Thoracic Surgery, Memorial Hospital, Bucharest, Romania.
Transl Lung Cancer Res ; 13(2): 334-344, 2024 Feb 29.
Article in En | MEDLINE | ID: mdl-38496690
ABSTRACT

Background:

Traditional thoracotomy, an invasive surgical procedure, has been the standard approach for extended lobectomy in treating non-small cell lung cancer (NSCLC). However, minimally invasive surgery (MIS) has gained traction with advancements in surgical techniques. Despite this, the outcomes of extended lobectomy via a minimally invasive approach remain largely uncharted. Using the comprehensive National Cancer Database (NCDB), our research aimed to clarify the safety, feasibility, and efficacy of minimally invasive extended lobectomy in patients diagnosed with NSCLC.

Methods:

Our study encompassed a selection of patients with NSCLC who underwent extended lobectomy (defined as lobectomy or bilobectomy with chest wall, diaphragm or pericardial resection) between 2010 and 2014. Through propensity score matching (PSM), we ensured a balanced comparison between patients who underwent MIS and those who opted for the traditional open extended lobectomy. Both univariate and multivariate analyses were employed to discern whether the surgical approach had any significant impact on the prognosis of patients undergoing this specific procedure.

Results:

Before PSM, our dataset included 3,934 patients. After 12 PSM, the MIS group included 683 cases, while the open group included 1,317 cases. One notable finding was the reduced average postoperative hospital stay for the MIS group at 7.15 days compared to the open group at 8.40 days (P<0.001). Furthermore, the 5-year survival rate was similar, with the MIS group at 53.1% and the open group at 51.3% (P=0.683).

Conclusions:

The results of our study suggest that MIS for extended lobectomy not only is safe and feasible but also is oncologically effective. However, it is imperative to note that these encouraging findings necessitate further validation through prospective studies to ascertain the full scope of benefits and potential risks associated with MIS.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2024 Type: Article Affiliation country: China